1. Home
  2. AMRC vs RLAY Comparison

AMRC vs RLAY Comparison

Compare AMRC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameresco Inc.

AMRC

Ameresco Inc.

HOLD

Current Price

$30.67

Market Cap

1.8B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.13

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRC
RLAY
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
AMRC
RLAY
Price
$30.67
$8.13
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$33.22
$16.00
AVG Volume (30 Days)
468.7K
2.3M
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
18.87
N/A
EPS
1.19
N/A
Revenue
$1,883,767,000.00
$8,355,000.00
Revenue This Year
$9.83
$20.47
Revenue Next Year
$9.83
N/A
P/E Ratio
$24.61
N/A
Revenue Growth
12.22
N/A
52 Week Low
$8.49
$1.78
52 Week High
$44.93
$9.04

Technical Indicators

Market Signals
Indicator
AMRC
RLAY
Relative Strength Index (RSI) 46.11 53.65
Support Level $28.72 $8.25
Resistance Level $30.90 $8.58
Average True Range (ATR) 1.24 0.46
MACD 0.13 -0.05
Stochastic Oscillator 58.50 33.46

Price Performance

Historical Comparison
AMRC
RLAY

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: